Home/Pipeline/eOPN3‑Movement Disorders

eOPN3‑Movement Disorders

Movement Disorders (Parkinson's, Essential Tremor)

PreclinicalActive

Key Facts

Indication
Movement Disorders (Parkinson's, Essential Tremor)
Phase
Preclinical
Status
Active
Company

About Modulight Bio

Israeli optogenetics biotech leveraging light‑controlled GPCRs to treat refractory neurological disorders.

View full company profile